查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771714

美国心血管设备市场规模、份额、趋势分析报告：按产品、最终用途和细分市场预测，2025 年至 2033 年

U.S. Cardiovascular Devices Market Size, Share & Trends Analysis Report By Product (Diagnostic & Monitoring, Surgical Devices), By End-use (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

美国心血管设备市场概况

美国心血管设备市场规模预计在 2024 年为 223.9 亿美元，预计到 2033 年将达到 376.6 亿美元，2025 年至 2033 年的复合年增长率为 5.8%。心血管设备是专门用于诊断或治疗心臟或血管疾病的医疗设备，包括心律调节器、支架、人工瓣膜、心臟去颤器、血管成形术设备和心导管等设备。

心血管疾病盛行率的上升是推动市场成长的因素之一。根据美国心臟协会 (AHA) 的数据，2024 年 1 月美国因心血管疾病死亡的人数将达到 931,578 人，比前一年增加近 3,000 人。此外，年龄调整后的心血管疾病死亡率将达到每 10 万人 233.3 人，比前一年增加 4.0%。死亡率的上升趋势凸显了心血管疾病带来的持续挑战，并凸显了对创新心血管设备和干预措施的迫切需求。

此外，根据美国心臟协会 (AHA) 2024 年 6 月发布的报告，到 2050 年，心血管疾病 (CVD) 可能影响超过 1.84 亿美国人，占总人口的 61% 以上。随着盛行率的上升，CVD 相关的医疗保健费用预计将大幅上升，并可能达到 1.8 兆美元。病例数和相关费用的上升凸显了心血管设备发展亟需的紧迫性。因此，随着对支持早期诊断、预防保健和有效治疗方案的创新技术的需求日益增长，以应对 CVD 对公众健康的广泛影响，美国心血管设备市场预计将经历显着增长。

日益增多的宣传活动和政府主导的心血管疾病早期发现筛检计画使更多患者能够及时接受诊断和治疗，从而促进了市场的扩张。根据美国心臟协会 (AHA)、美国心臟病学会 (ACC)、美国胸腔科医师学会 (ACCP) 和心律学会 (HRS) 于 2023 年 11 月发布的 2023 年心房颤动诊断和管理指南，强调了意识提升和实施定期筛检的重要性，尤其是对于老年人等高风险族群。这些指南提倡定期进行脉搏和心电图筛检，以确保早期发现和有效管理心血管疾病。例如，早期发现和治疗心房颤动至关重要，因为它可以显着降低中风和其他严重併发症的风险。

针对心血管疾病 (CVD) 的筛检计画效率将推动市场成长。根据施普林格·自然 (Springer Nature) 报道，2024 年 6 月，一项心臟病学报告综述将检验筛检计画的影响。这篇综述将重点介绍 STROKESTOP 和 AF-SCREEN 等多中心研究的结果，这些研究表明，有针对性的筛检可显着提高心血管疾病 (CVD) 的检出率，尤其是在老年人群中。这篇综述强烈支持建立全国筛检倡议，以应对与心房颤动相关的併发症日益加重的负担，并强调早期发现和介入的关键作用。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国心血管设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国心血管设备市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章美国心血管设备市场：按产品分類的估计和趋势分析

  • 美国心血管设备市场：产品仪表板
  • 美国心血管设备市场：产品差异分析
  • 美国心血管设备市场规模、预测与趋势分析（按产品，2021-2033 年）
  • 诊断和监控
    • 心电图
    • 植入式心臟监测仪
    • 心电图监测
    • 移动心电遥测
    • MRI
    • 心血管超音波
    • 心臟诊断导管插入术
    • PET扫描仪
  • 手术设备
    • 心臟再同步治疗（CRT）
    • 植入式心臟整流去颤器（ICD）
    • 起搏器
    • 冠状动脉支架
    • 导管
    • 导管导引线
    • 套管
    • 阀门
    • 阻塞设备

第五章美国心血管设备市场：最终用途、估计与趋势分析

  • 美国心血管设备市场：最终用户仪表板
  • 美国心血管设备市场：最终用途差异分析
  • 美国心血管设备市场规模、预测和趋势分析（按最终用途，2021-2033 年）
  • 医院
  • 门诊手术中心
  • 诊断中心
  • 其他的

第六章 竞争态势

  • 主要製造商的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 2024年主要企业市场占有率分析
    • Abbott
    • GE HealthCare
    • Edwards Lifesciences Corporation
    • Siemens Healthineers AG
    • Canon Medical Systems
    • B. Braun SE
    • LivaNova, Inc.
    • Cardinal Health
    • Medtronic
    • Boston Scientific Corporation
    • WL Gore & Associates, Inc.
    • BIOTRONIK SE & Co. KG
Product Code: GVR-4-68040-631-2

U.S. Cardiovascular Devices Market Summary

The U.S. cardiovascular devices market size was estimated at USD 22.39 billion in 2024 and is projected to reach USD 37.66 billion by 2033, growing at a CAGR of 5.8% from 2025 to 2033. A cardiovascular device is a medical tool explicitly used to diagnose or treat diseases of the heart and blood vessels, including instruments like pacemakers, stents, artificial valves, defibrillators, angioplasty tools, and cardiac catheters.

The rising incidence of cardiovascular diseases is one of the factors boosting market growth. According to the America Heart Association (AHA), in January 2024, there were 931,578 deaths in the U.S. attributed to cardiovascular disease, marking an increase of nearly 3,000 compared to the previous year. Additionally, the age-adjusted death rate from cardiovascular conditions rose to 233.3 per 100,000 individuals, reflecting a 4.0% increase from the prior year. This upward trend in mortality rates emphasizes the ongoing challenges posed by cardiovascular diseases, highlighting the critical need for innovative cardiovascular devices and interventions.

Moreover, as per the American Heart Association (AHA) article published in June 2024, cardiovascular disease (CVD) could affect over 184 million Americans, more than 61% of the population, by 2050. Alongside this expected rise in prevalence, CVD-related healthcare costs are expected to escalate dramatically, potentially reaching USD 1.8 trillion. This forecasted growth in cases and associated costs highlights an urgent need for advancements in cardiovascular devices. Therefore, the U.S. cardiovascular devices market is positioned for substantial growth as demand intensifies for innovative technologies that support early diagnosis, preventive care, and effective treatment solutions to manage the widespread impact of CVD on public health.

Increasing awareness campaigns and government-initiated screening programs for early detection of CVDs contribute to market expansion by ensuring more patients receive timely diagnosis and treatment. According to the American Heart Association, Inc. article published in November 2023, the 2023 guidelines from the American Heart Association (AHA), American College of Cardiology (ACC), American College of Chest Physicians (ACCP), and the Heart Rhythm Society (HRS) for the diagnosis & management of AFib stress the importance of raising awareness and implementing routine screening, especially in high-risk groups like older adults. These guidelines advocate for regular pulse and ECG screenings to ensure early detection and effective management of CVDs. For instance, early identification and treatment of AFib are crucial as they can significantly lower the risk of stroke and other serious complications.

The efficiency of targeted screening programs for CVDs fuels market growth. According to Springer Nature, in June 2024, a review of cardiology reports will examine the impact of screening programs. It highlights findings from multicenter studies, such as STROKESTOP and AF-SCREEN, which show that targeted screening greatly enhances the detection of CVDs, especially among older adults. The review strongly supports establishing national screening initiatives to address the growing burden of AFib-related complications, highlighting the critical role of early detection and intervention.

U.S. Cardiovascular Devices Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. cardiovascular devices market report based on product, and end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostic & Monitoring
    • ECG
    • Implantable Cardiac Monitors
    • Holter Monitors
    • Mobile Cardiac Telemetry
    • MRI
    • Cardiovascular Ultrasound
    • Cardiac Diagnostic Catheters
    • PET Scanner
  • Surgical Devices
    • Cardiac Resynchronization Therapy (CRT)
    • Implantable Cardioverter Defibrillators (ICDs)
    • Pacemakers
    • Coronary Stents
    • Catheters
    • Guidewires
    • Cannula
    • Valves
    • Occlusion Devices
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity price analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Segment
    • 2.2.2. End Use Segment
    • 2.2.3. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Cardiovascular Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiovascular diseases (CVDs)
      • 3.2.1.2. Increasing awareness and screening programs
      • 3.2.1.3. Technological advancement in CVDs devices
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs associated with the devices
      • 3.2.2.2. Product Recalls
  • 3.3. U.S. Cardiovascular Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Cardiovascular Devices Market: Product Estimates & Trend Analysis

  • 4.1. U.S. Cardiovascular Devices Market: Product Dashboard
  • 4.2. U.S. Cardiovascular Devices Market: Product Movement Analysis
  • 4.3. U.S. Cardiovascular Devices Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Diagnostic & Monitoring
    • 4.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.2. ECG
      • 4.4.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.3. Implantable Cardiac Monitors
      • 4.4.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.4. Holter Monitors
      • 4.4.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.5. Mobile Cardiac Telemetry
      • 4.4.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.6. MRI
      • 4.4.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.7. Cardiovascular Ultrasound
      • 4.4.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.8. Cardiac Diagnostic Catheters
      • 4.4.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.4.9. PET Scanner
      • 4.4.9.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 4.5. Surgical Devices
    • 4.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.2. Cardiac Resynchronization Therapy (CRT)
      • 4.5.2.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.3. Implantable Cardioverter Defibrillators (ICDs)
      • 4.5.3.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.4. Pacemakers
      • 4.5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.5. Coronary Stents
      • 4.5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.6. Catheters
      • 4.5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.7. Guidewires
      • 4.5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.8. Cannula
      • 4.5.8.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.9. Valves
      • 4.5.9.1. Market estimates and forecast 2021 - 2033 (USD Million)
    • 4.5.10. Occlusion Devices
      • 4.5.10.1. Market estimates and forecast 2021 - 2033 (USD Million)

Chapter 5. U.S. Cardiovascular Devices Market: End Use Estimates & Trend Analysis

  • 5.1. U.S. Cardiovascular Devices Market: End Use Dashboard
  • 5.2. U.S. Cardiovascular Devices Market: End Use Movement Analysis
  • 5.3. U.S. Cardiovascular Devices Market Size & Forecasts and Trend Analysis, by End Use , 2021-2033 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 5.5. Ambulatory Surgical Centers
    • 5.5.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 5.6. Diagnostic Centers
    • 5.6.1. Market estimates and forecast 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecast 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Manufacturers
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2024
    • 6.3.4. Abbott
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. GE HealthCare
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Edwards Lifesciences Corporation
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Siemens Healthineers AG
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Canon Medical Systems
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. B. Braun SE
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. LivaNova, Inc.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Cardinal Health
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Medtronic
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. Boston Scientific Corporation
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives
    • 6.3.14. W. L. Gore & Associates, Inc.
      • 6.3.14.1. Company overview
      • 6.3.14.2. Financial performance
      • 6.3.14.3. Product benchmarking
      • 6.3.14.4. Strategic initiatives
    • 6.3.15. BIOTRONIK SE & Co. KG
      • 6.3.15.1. Company overview
      • 6.3.15.2. Financial performance
      • 6.3.15.3. Product benchmarking
      • 6.3.15.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. cardiovascular devices market, by product, 2021 - 2033 (USD Million)
  • Table 4. U.S. cardiovascular devices market, by end use, 2021 - 2033 (USD Million)
  • Table 5. Key companies undergoing expansions
  • Table 6. Key companies undergoing acquisitions
  • Table 7. Key companies undergoing collaborations
  • Table 8. Key companies launching new products
  • Table 9. Key companies undergoing partnerships
  • Table 10. Key companies undertaking other strategies

List of Figures

  • Fig. 1 U.S. cardiovascular devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 U.S. cardiovascular devices market revenues, 2024, (USD Millions)
  • Fig. 9 Market driver relevance analysis (Current & future impact)
  • Fig. 10 Market restraint relevance analysis (Current & future impact)
  • Fig. 11 Porter's five forces analysis
  • Fig. 12 PESTLE analysis
  • Fig. 13 U.S. cardiovascular devices market: Product outlook:
  • Fig. 14 U.S. cardiovascular devices market: Product movement analysis
  • Fig. 15 Segment dashboard
  • Fig. 16 Diagnostic and monitoring devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 ECG market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Implantable cardiac monitors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Holter monitors market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Mobile cardiac telemetry market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Cardiovascular ultrasound market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Cardiac diagnostic catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Pet scan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 MRI market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Cardiac resynchronization therapy (CRT) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Implantable cardioverter defibrillators (ICDs) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Pacemakers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Coronary stents market estimates and forecasts, 2021 - 2033 (USD Million
  • Fig. 30 Catheters market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Guidewires market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Cannula market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Valves market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Occlusion devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. cardiovascular devices market: End use outlook:
  • Fig. 36 U.S. cardiovascular devices market: End use movement analysis
  • Fig. 37 Hospitals market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Ambulatory surgical centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Diagnostic centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Others market estimates and forecasts, 2021 - 2033 (USD Million)